Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…These diagnostic categories were selected based on the frequency with which patients received platelet transfusions and/or prior studies suggesting a possible impact of platelet transfusions on patient outcomes. The four diagnostic categories included were Hematology/ Oncology (Hem/Onc), 4 Trauma, 22,23 Cardiac Surgery, [24][25][26] and Intracerebral Hemorrhage (ICH). 5,27 For the dosedependent analysis, bidirectional mismatches were tabulated as both major and minor mismatches.…”
Section: Discussionmentioning
confidence: 99%
“…These diagnostic categories were selected based on the frequency with which patients received platelet transfusions and/or prior studies suggesting a possible impact of platelet transfusions on patient outcomes. The four diagnostic categories included were Hematology/ Oncology (Hem/Onc), 4 Trauma, 22,23 Cardiac Surgery, [24][25][26] and Intracerebral Hemorrhage (ICH). 5,27 For the dosedependent analysis, bidirectional mismatches were tabulated as both major and minor mismatches.…”
Section: Discussionmentioning
confidence: 99%
“…To obviate the hemolytic complications of minor ABO incompatible platelets, some centres resolve to only transfusing major ABO incompatible platelets or ABO‐compatible platelets, the latter also having the lowest reported rate of transfusion reactions and reduced de novo red cell alloimmunization 7,9 . While this practice mildly increases outdating of platelets, it has been associated with improved patient outcomes in some settings and some studies have reported an associated patient survival benefit 9–13 . This is not always feasible for most blood banks given the short shelf life of platelet transfusions, the relative rarity of B and AB donors and the occasional need of HLA‐matched platelets.…”
Section: Discussionmentioning
confidence: 99%
“…7,9 While this practice mildly increases outdating of platelets, it has been associated with improved patient outcomes in some settings and some studies have reported an associated patient survival benefit. [9][10][11][12][13] This is not always feasible for most blood banks given the short shelf life of platelet transfusions, the relative rarity of B and AB donors and the occasional need of HLA-matched platelets.…”
Section: Isohemagglutinin Titrementioning
confidence: 99%